Ship a smart thermostat, an infusion pump, a managed switch, or a point-of-sale terminal today, and most of the code inside it is not something your engineers wrote line by line. Embedded software and independent software vendor (ISV) products are assembled from compiled third-party libraries, RTOS kernels, chipset SDKs, and vendor binary blobs — much of it delivered with no accompanying source code. That reality built an entire product category: binary composition analysis, a market Black Duck has dominated since acquiring binary-scanning specialist Protecode in 2020, and has doubled down on since spinning out of Synopsys in a 2024 sale to Clearlake Capital. But regulatory deadlines — the EU Cyber Resilience Act's September 2026 reporting obligations, FDA's premarket cybersecurity requirements — are pushing embedded vendors and ISVs past "what open source is in my binary" toward "can I prove how this binary was built and who touched it." That's a materially different problem, and it's where legacy binary SCA tooling starts to show its age.
What makes embedded and ISV software security fundamentally different from web AppSec?
The core difference is that embedded and ISV vendors frequently can't see, patch, or even fully identify their own dependencies the way a SaaS team can. A web team controls its runtime, redeploys in minutes, and can grep a package.json or pom.xml to see exactly what's installed. An embedded team inherits a chipset vendor's SDK as a compiled .so file, links a Bluetooth stack with no build manifest, and ships firmware that may sit in the field for a decade or more with no guaranteed update path. A medical infusion pump or industrial PLC built in 2016 can still be running in a hospital or a plant floor in 2026, executing an OpenSSL build that hasn't been touched since the day it was compiled. Source-based SCA tools that scan manifests are effectively blind to this world, because there is no manifest — just a binary and a customer asking, three years post-ship, "is my device affected by the vulnerability in the news this week?"
Why did Black Duck build an entire business around binary analysis for embedded software?
Because standard, manifest-based SCA cannot see components that arrive as compiled binaries with no source or build metadata — which describes the majority of embedded and firmware supply chains. Black Duck's answer was Black Duck Binary Analysis (BDBA), built on technology from its 2020 acquisition of Protecode, which fingerprints binaries against a knowledge base of known open source code snippets and version signatures to identify what's inside a compiled artifact without needing source. It's a genuinely useful capability, and it's the reason Black Duck has such deep penetration in automotive, industrial, medical device, and network equipment vendors — sectors where "just scan the repo" was never a realistic option. When Synopsys's Software Integrity Group was sold to Clearlake Capital for roughly $2.1 billion in 2024 and re-formed as the independent Black Duck Software, binary analysis for embedded and ISV customers was one of the crown jewels in that deal, alongside the company's long-running annual Open Source Security and Risk Analysis (OSSRA) report, which has for years documented that the overwhelming majority of commercial codebases contain open source and that a meaningful share carry known high-risk vulnerabilities.
What's forcing embedded vendors and ISVs to formalize a security program right now?
It's regulation and procurement mandates catching up to a decade of "we'll deal with it later," not just breaches. The EU Cyber Resilience Act (Regulation 2024/2847) entered into force in December 2024, and its vulnerability and incident reporting obligations — a 24-hour early warning and 72-hour follow-up to ENISA for actively exploited vulnerabilities — become enforceable on September 11, 2026, with full compliance, including SBOM and secure-by-design documentation under Annex I, required by December 11, 2027. On the medical device side, FDA's Section 524B authority has meant that since October 2023 the agency can — and does — issue "refuse to accept" decisions on premarket submissions that lack a software bill of materials and a documented vulnerability management plan. ISVs selling into finance and government face a parallel push: NIST's Secure Software Development Framework (SP 800-218), referenced by OMB Memo M-22-18, now requires vendors to self-attest to secure development practices before agencies can use their software at all. None of this asks "do you have antivirus." It asks "can you produce an accurate, current SBOM and prove your build process on demand," which is a fundamentally different bar than the one most embedded teams were built to clear.
Where does binary-only composition analysis fall short for a modern ISV security program?
It stops at "what open source is in this binary and does it match a known CVE," not "was this binary actually built the way we believe it was." Binary composition analysis is inventory-plus-lookup: fingerprint the code, match it against known snippets, flag known CVEs, done. That's necessary but it doesn't verify build provenance, doesn't detect a compromised build pipeline or a dependency-confusion attack injecting a malicious package before compilation, and doesn't produce a cryptographically verifiable attestation (SLSA, in-toto) that a customer or auditor can check independently. The XZ Utils backdoor, discovered by a Microsoft engineer on March 29, 2024, and tracked as CVE-2024-3094, is the clearest recent illustration: the compromise was introduced by a trusted maintainer account over roughly two years of social-engineered contribution, and it altered the build process itself rather than shipping a recognizably malicious known-bad snippet. A binary fingerprinting scan looking for known-vulnerable code wouldn't have caught it pre-disclosure, because the problem wasn't "old vulnerable component," it was "the build pipeline itself was compromised." Embedded and ISV programs that stop at component inventory inherit that exact blind spot, and they inherit it for years, because embedded artifacts don't get rebuilt and redeployed the way a web service does.
How should embedded vendors and ISVs actually structure a security program to meet these demands?
By pairing component visibility with build and provenance controls across the entire lifecycle, not treating an SBOM as a one-time deliverable generated right before a release ships. In practice that means: continuous SBOM generation wired into the actual CI/CD pipeline rather than a quarterly binary scan bolted on afterward; hybrid source-plus-binary analysis so vendored code and linked third-party binaries both get covered; cryptographic build attestation so a customer or regulator can verify provenance instead of trusting a PDF; vulnerability response SLAs mapped explicitly to the CRA's 24-hour/72-hour reporting clock rather than a generic "we patch quarterly" policy; and a long-tail support plan that accounts for the fact that an embedded device shipped today may need vulnerability answers a decade from now, long after the original build environment and even the original engineering team are gone. Vendors that treat this as a documentation exercise for the next audit will keep discovering, mid-incident, that they can't actually answer "which of our 40,000 deployed devices run the affected component" fast enough to matter.
How Safeguard Helps
Safeguard is built for exactly the gap that binary-only scanning leaves open: proving not just what's in your software, but how it got there. Instead of a periodic binary fingerprinting pass, Safeguard generates SBOMs continuously as part of your actual build pipeline, tracking source and compiled artifacts together so vendored libraries, statically linked code, and third-party SDK binaries are all visible in one inventory rather than split across separate tools. Every build gets a cryptographically verifiable provenance record, so when a customer, auditor, or regulator asks how a specific firmware image was produced, you can answer with an attestation rather than a spreadsheet.
For embedded and ISV teams specifically, Safeguard maps active monitoring to the realities of long device lifecycles: once a component ships in a device that will be in the field for years, Safeguard keeps watching it for newly disclosed CVEs, maintainer or license changes, and supply chain anomalies, and alerts your team with enough lead time to meet reporting windows like the CRA's 24-hour/72-hour clock instead of scrambling after the fact. That includes detection tuned for the kind of build-pipeline and maintainer-trust compromises — the XZ Utils pattern — that fingerprint-matching alone will always miss, because Safeguard is watching the pipeline and the dependency graph, not just the finished binary.
The result is a security program that satisfies what FDA, the EU CRA, and enterprise procurement teams are actually asking for now: not a one-time inventory, but continuous, provable answers about what's running in your products and how it was built — for as long as that product is still in someone's hospital, factory floor, or network closet. If your embedded or ISV security program is still built around point-in-time binary scans, that's the gap worth closing next.